Meiji Seika’s Korean JV Passes GMP Inspection by PMDA, Preparing for Contract Production of Nesp Biosimilar

Meiji Seika Pharma said on September 26 that DM Bio, a joint venture with Dong-A Socio Holdings of South Korea, has passed a GMP compliance inspection for biopharmaceutical manufacturing by Japan’s Pharmaceuticals and Medical Devices Agency (PMDA). DM Bio is...read more